Alpha Financial Statements From 2010 to 2025

DRTS Stock  USD 3.39  0.12  3.67%   
Alpha Tau's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Alpha Tau's valuation are provided below:
Alpha Tau Medical does not presently have any fundamental signals for analysis.
Check Alpha Tau financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alpha Tau's main balance sheet or income statement drivers, such as , as well as many indicators such as . Alpha financial statements analysis is a perfect complement when working with Alpha Tau Valuation or Volatility modules.
Check out the analysis of Alpha Tau Correlation against competitors.

Alpha Tau Medical Company Shares Outstanding Analysis

Alpha Tau's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Alpha Tau Shares Outstanding

    
  84.82 M  
Most of Alpha Tau's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpha Tau Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Alpha Tau Medical has 84.82 M of shares currently outstending. This is 53.02% lower than that of the Biotechnology sector and 20.62% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 85.17% higher than that of the company.

Alpha Tau Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alpha Tau's current stock value. Our valuation model uses many indicators to compare Alpha Tau value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alpha Tau competition to find correlations between indicators driving Alpha Tau's intrinsic value. More Info.
Alpha Tau Medical is rated # 4 in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Alpha Tau by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About Alpha Tau Financial Statements

Alpha Tau shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Alpha Tau investors may analyze each financial statement separately, they are all interrelated. The changes in Alpha Tau's assets and liabilities, for example, are also reflected in the revenues and expenses on on Alpha Tau's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of solid cancer In Israel and the United States. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel. Alpha Tau is traded on NASDAQ Exchange in the United States.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Alpha Stock Analysis

When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.